Skip to content

Comparison of the effect of bupivacaine liposome and bupivacaine hydrochloride on postoperative Quality of Recovery in patients undergoing laparoscopic total hysterectomy by anterior quadratus lumborum block at lateral supra-arcuate ligament

Comparison of the effect of bupivacaine liposome and bupivacaine hydrochloride on postoperative Quality of Recovery in patients undergoing laparoscopic total hysterectomy by anterior quadratus lumborum block at lateral supra-arcuate ligament

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104281
Enrollment
Unknown
Registered
2025-06-13
Start date
2025-06-23
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoma of uterus

Interventions

Bupivacaine liposomal group:20ml/133mg liposome bupivacaine on each side was used to perform anterior and bilateral block of quadrate lumboes muscle superior arcuate ligament
Bupivacaine group:20ml/50mg bupivacaine hydrochloride (0.25%) on each side was used for anterior and bilateral block of quadrate lumbosi muscle of arcuate ligament

Sponsors

Chengdu Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 18~75 years old; 2.BMI 16~29 kg/m^2; 3.ASA I.~II level; 4. Elective laparoscopic total hysterectomy.

Exclusion criteria

Exclusion criteria: 1. Allergy to anesthetic drugs in the study protocol; 2. Patients with infection at the puncture site; 3. Obvious abnormality of coagulation function; 4. Lumbar and abdominal radiotherapy or history of surgery; 5. Neuromuscular disease or psychiatric disease; 6. Severe liver and kidney insufficiency; 7. Refusal to undergo nerve block or refusal to use an intravenous analgesic pump; 8. Inability to understand and communicate; 9. Long-term use of sedative and analgesic drugs.

Design outcomes

Primary

MeasureTime frame
QoR-40 after 24h surgery;

Secondary

MeasureTime frame
QoR-40 1 day before surgery;QoR-40 after 48h surgery;QoR-40 after 72h surgery;Resting and exercise VAS scores at 12h, 24h, 48h and 72h after surgery;Intraoperative analgesic use;Number of analgesic remedies;Intraoperative vasoactive drug use;Operation duration;First time out of bed;Gastrointestinal function recovery time;Discharge time (Surgery - Discharge);Nausea and vomiting, skin itching, drowsiness, vertigo and other adverse reactions and nerve block complications occurred;

Countries

China

Contacts

Public ContactYi Mingling

Chengdu Fifth People's Hospital

16823797@qq.com+86 136 9603 8619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026